Prize-Based Incentives for Smoking Cessation Among People With HIV: A Sequential Multiple Assignment Randomized Trial

被引:2
|
作者
Ledgerwood, David M. [1 ]
Lundahl, Leslie H. [1 ]
Greenwald, Mark K. [1 ]
Cohn, Jonathan [2 ]
Arfken, Cynthia L. [1 ]
机构
[1] Wayne State Univ, Dept Psychiat & Behav Neurosci, Ste 2C,3901 Chrysler Dr, Detroit, MI 48201 USA
[2] Wayne State Univ, Dept Internal Med, Div Infect Dis, Detroit, MI 48201 USA
关键词
QUALITY-OF-LIFE; CONTINGENCY MANAGEMENT; TOBACCO USE; SMOKERS; INTERVENTIONS; ABSTINENCE; DEPENDENCE; VARENICLINE; EFFICACY; USERS;
D O I
10.1093/ntr/ntae243
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: Contingency management (CM) is an incentive-based approach that has demonstrated efficacy for smoking cessation in various populations. There is an unmet need for feasible and effective smoking cessation interventions in people with HIV (PWH). The purpose of this study was to assess the efficacy of prize-based CM for smoking cessation in PWH using a Sequential Multiple Assignment Randomization Trial (SMART) design selected to tailor intervention intensity based on early treatment response. Methods: During phase I, 129 participants were randomly assigned to high-magnitude prize CM (HM-CM) or standard of care (SoC) for 4 weeks. Participants who did not reduce smoking were randomized in phase II to continued counseling with HM-CM plus monitoring support or only continued monitoring support for 8 weeks. Participants who reduced smoking were randomized to booster monitoring with low-magnitude CM or no additional care. Outcomes were biochemically verified smoking reduction and 7-day abstinence prevalence at posttreatment, 6-month, and 12-month follow-up. Results: Phase I responders (based on biochemical indicators of smoking reduction) were significantly less likely to return to smoking (during treatment and at 6 and 12 months) if they received low-magnitude incentives. Notably, initial exposure to CM versus SoC did not increase the rate of phase I response, and high-magnitude incentives later in treatment did not lead to greater smoking cessation for early-treatment nonresponders. Conclusions: Weekly CM sessions in the first 4 weeks of smoking cessation intervention did not perform significantly better than SoC. However, brief booster CM sessions aimed at maintaining early smoking cessation hold clinical promise and warrant further investigation. Implications: This represents the first trial to examine the use of CM for smoking cessation among PWH within the context of a SMART design.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Effects of Large Financial Incentives for Long-Term Smoking Cessation A Randomized Trial
    Etter, Jean-Francois
    Schmid, Felicia
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (08) : 777 - 785
  • [32] Tobacco Smoking, Smoking Cessation, and Life Expectancy Among People With HIV in South Africa
    Thielking, A.
    Fitzmaurice, K.
    Sewpaul, R.
    Dike, L.
    Freedberg, K.
    Hyle, E.
    Levy, D.
    Paltiel, A. D.
    Rigotti, N.
    Siedner, M.
    Reddy, K. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [33] Optimizing behavioral and pharmacological smoking cessation interventions among people with HIV
    Himelhoch, Seth
    Kelly, Deana
    DeFilippi, Chris
    Taylor, Gregory
    Bennett, Melanie
    Medoff, Deborah
    Li, Lan
    Christenson, Robert
    Potts, Wendy
    Shuter, Jonathan
    AIDS, 2024, 38 (05) : 669 - 678
  • [34] Pilot Randomized Clinical Trial of a Text Messaging-Based Intervention for Smoking Cessation Among Young People Experiencing Homelessness
    Tucker, Joan S.
    Linnemayr, Sebastian
    Pedersen, Eric R.
    Shadel, William G.
    Zutshi, Rushil
    DeYoreo, Maria
    Cabreros, Irineo
    NICOTINE & TOBACCO RESEARCH, 2021, 23 (10) : 1691 - 1698
  • [35] Effect of Flavored on! Nicotine Pouch Products on Smoking Behaviors: Protocol for a Sequential, Multiple Assignment, Randomized Controlled Trial
    Cheng, Hui G.
    Rose, Jed E.
    Karelitz, Joshua L.
    Botts, David R.
    Botts, Tanaia L.
    Willette, Perry N.
    Cohen, Gal
    JMIR RESEARCH PROTOCOLS, 2024, 13
  • [36] Evaluation of an integrated treatment to address smoking cessation and anxiety/depressive symptoms among people living with HIV: Study protocol for a randomized controlled trial
    Garey, Lorra
    Wirtz, Megan R.
    Labbe, Allison K.
    Zvolensky, Michael J.
    Smits, Jasper A. J.
    Giordano, Thomas P.
    Rosenfield, David
    Robbins, Gregory K.
    Levy, Douglas E.
    McKetchnie, Samantha M.
    Bell, Tanisha
    O'Cleirigh, Conall
    CONTEMPORARY CLINICAL TRIALS, 2021, 106
  • [37] Incentives for Viral Suppression in People Living with HIV: A Randomized Clinical Trial
    Silverman, Kenneth
    Holtyn, August F.
    Rodewald, Andrew M.
    Siliciano, Robert F.
    Jarvis, Brantley P.
    Subramaniam, Shrinidhi
    Leoutsakos, Jeannie-Marie
    Getty, Carol-Ann
    Ruhs, Sebastian
    Marzinke, Mark A.
    Fingerhood, Michael
    AIDS AND BEHAVIOR, 2019, 23 (09) : 2337 - 2346
  • [38] Incentives for Viral Suppression in People Living with HIV: A Randomized Clinical Trial
    Kenneth Silverman
    August F. Holtyn
    Andrew M. Rodewald
    Robert F. Siliciano
    Brantley P. Jarvis
    Shrinidhi Subramaniam
    Jeannie-Marie Leoutsakos
    Carol-Ann Getty
    Sebastian Ruhs
    Mark A. Marzinke
    Michael Fingerhood
    AIDS and Behavior, 2019, 23 : 2337 - 2346
  • [39] A randomized controlled trial of multiple tailored messages for smoking cessation among callers to the cancer information service
    Strecher, VJ
    Marcus, A
    Bishop, K
    Fleisher, L
    Stengle, W
    Levinson, A
    Fairclough, DL
    Wolfe, P
    Morra, M
    Davis, S
    Warnecke, R
    Heimendinger, J
    Nowak, M
    JOURNAL OF HEALTH COMMUNICATION, 2005, 10 : 105 - 118
  • [40] The Relationship Between Cigarette Dependence and Cessation Methods: Implications for Smoking Cessation Among People With HIV
    Wirtz, Megan R.
    Stanton, Amelia M.
    Manohar, Rohin
    Labbe, Allison K.
    Zvolensky, Michael J.
    Smits, Jasper A. J.
    Hoeppner, Bettina
    O'cleirigh, Conall
    JOURNAL OF STUDIES ON ALCOHOL AND DRUGS, 2023, 84 (05) : 772 - 780